Estetrol and its implications for contraception, venous thromboembolism, and breast cancer: an integrative review
Authors:
- Marcos Arêas MarquesMMMarcos Arêas Marques
- Suzanna Maria Viana SanchesSSSuzanna Maria Viana Sanches
- Monique Magnavita Borba da Fonseca CerqueiraMonique Magnavita Borba da Fonseca Cerqueira
- Marina Araujo ZulchnerMZMarina Araujo Zulchner
- André Luiz Malavasi Longo de OliveiraAOAndré Luiz Malavasi Longo de Oliveira
Open Access
- 1 January 2026
- journal article
- Published by FapUNIFESP (SciELO) in Jornal Vascular Brasileiro
- Vol. 25
Abstract
Combined oral contraceptives (COCs) provide benefits beyond contraception but are associated with risks such as venous thromboembolism (VTE) and breast cancer. This integrative review aimed to evaluate the efficacy and safety of estetrol (E4)-containing COCs regarding their risk of VTE and breast cancer. The PubMed database was searched for preclinical and clinical studies published through 2025. Data extraction followed a structured protocol, resulting in the inclusion of 15 studies in the review. Available evidence suggests that E4 has limited effects on the liver and the coagulation cascade, in addition to being associated with less breast tissue proliferation compared to other estrogens. However, clinical evidence regarding hard outcomes, including the long-term incidence of VTE and breast cancer, remains limited. Current evidence suggests a promising efficacy and safety profile but remains insufficient to rule out the risks of VTE and breast cancer.Keywords
This publication has 32 references indexed in Scilit:
- Hormonal Contraceptive Formulations and Breast Cancer Risk in Adolescents and Premenopausal WomenJAMA Oncology, 2025
- Estetrol: From Preclinical to Clinical Pharmacology and Advances in the Understanding of the Molecular Mechanism of ActionDrugs in R&D, 2023
- Estetrol-drospirenone combination oral contraceptive: North American phase 3 efficacy and safety resultsContraception, 2021
- Estetrol and Mammary Gland: Friends or Foes?Journal of Mammary Gland Biology and Neoplasia, 2021
- Effects of an oral contraceptive containing estetrol and drospirenone on ovarian functionContraception, 2021
- Endocrine and metabolic effects of an oral contraceptive containing estetrol and drospirenoneContraception, 2021
- Evaluation of the effect of a new oral contraceptive containing estetrol and drospirenone on hemostasis parametersContraception, 2020
- Tumor suppression, dose-limiting toxicity and wellbeing with the fetal estrogen estetrol in patients with advanced breast cancerJournal of Cancer Research and Clinical Oncology, 2020
- Reduced hemostatic effects with drospirenone-based oral contraceptives containing estetrol vs. ethinyl estradiolContraception, 2017
- Bleeding pattern and cycle control with estetrol-containing combined oral contraceptives: results from a phase II, randomised, dose-finding study (FIESTA)Contraception, 2016